发明名称 COMPOUNDS OF CYCLIC URETHAN OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF HUMAN AND OTHER MAMMALIAN TREATMENT SUFFERING WITH CARDIAC ARRHYTHMIA AND/OR ATRIAL FIBRILLATION, A PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PATIENTS WITH ARRHYTHMIA AND FIBRILLATION
摘要 FIELD: organic chemistry. SUBSTANCE: invention describes new cyclic urethans of the general formula (I) <EMI ID=0.223 HE=33 WI=75 TI=CHI> where X - phenyl; R - covalent bond; Y - furylidene; R<SB>1</SB>,R<SB>2</SB> and R<SB>3</SB> - hydrogen or chlorine atom; L - lower alkylamino bound at nitrogen atom to cyclic urethan nitrogen atom; R<SB>4</SB> - lower alkylene; A - unsaturated 6-membered heterocycle containing 1 or 2 nitrogen atoms that can be substituted with a lower alkyl or hydroxy(lower)alkyl being one of heterocycle A nitrogen atoms is bound with radical R<SB>4</SB>; R<SB>5</SB> - methylene, or their pharmaceutically acceptable salts. Cyclic urethans show activity against cardiac arrhythmia and atrial fibrillation. EFFECT: improved method of synthesis, enhanced effectiveness of compounds. 11 cl, 2 dwg, 1 tbl, 18 ex
申请公布号 RU2125568(C1) 申请公布日期 1999.01.27
申请号 RU19940016524 申请日期 1992.08.10
申请人 PROKTER EHND GEHMBL FARMAS'JUTIKALZ, INK. 发明人 STEHNFORD SAL'VATORE PELOZI;CHIA-NIEN JU
分类号 A61K31/42;A61K31/34;A61K31/41;A61K31/422;A61K31/495;A61P9/06;C07D263/14;C07D413/12;C07D413/14;(IPC1-7):C07D413/14;A61K31/535 主分类号 A61K31/42
代理机构 代理人
主权项
地址